# Direct Complete Versus Staged Complete Revascularization in Patients Presenting With Acute Coronary Syndromes and Multivessel Disease

Study · id `cardio:ct-nct03621501` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03621501](<https://clinicaltrials.gov/study/NCT03621501>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03621501

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 1525 participants.

## Technical summary

Registry record NCT03621501. Randomized; single masking; primary purpose treatment. Start 2018-06-22 (actual); primary completion 2022-10-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1525 participants (enrolled count; ClinicalTrials.gov record NCT03621501, source copy `cardio:ctgov-nct03621501-2022-11-08`, retrieved 2026-11-18)
- Started: 2018-06-22 (actual) (ClinicalTrials.gov record NCT03621501, source copy `cardio:ctgov-nct03621501-2022-11-08`, retrieved 2026-11-18)
- Primary completion: 2022-10-31 (actual) (ClinicalTrials.gov record NCT03621501, source copy `cardio:ctgov-nct03621501-2022-11-08`, retrieved 2026-11-18)
- Completion: 2026-10-31 (anticipated) (ClinicalTrials.gov record NCT03621501, source copy `cardio:ctgov-nct03621501-2022-11-08`, retrieved 2026-11-18)
- Countries: Netherlands (ClinicalTrials.gov record NCT03621501, source copy `cardio:ctgov-nct03621501-2022-11-08`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03621501-2022-11-08`, retrieved 2026-11-18)

## The registry's words

- Brief title: Direct Complete Versus Staged Complete Revascularization in Patients Presenting With Acute Coronary Syndromes and Multivessel Disease
- Acronym: BioVasc
- Condition: Acute Coronary Syndrome
- Intervention (Device): Percutaneous coronary intervention
- Lead sponsor: Erasmus Medical Center
- Lead sponsor class: OTHER
- Collaborator: Biotronik SE & Co. KG
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Erasmus Medical Center (`cardio:org-erasmus-medical-center`)
- Registry lists this organization as a collaborator: Biotronik SE & Co. KG (`cardio:org-biotronik-se-co-kg`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial (`cardio:pubmed-36889333`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Timing of Complete Multivessel Revascularization in Acute Coronary Syndrome: 2-Year Results of the BIOVASC Study (`cardio:pubmed-39722269`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 021777108ce451446f19f11f95c37870449baaefd042bbef9e2e7cea33ffb3fb
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
